Stockreport

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report

MiNK Therapeutics, Inc.  (INKT) 
PDF NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, a [Read more]